dsdsa

product

Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our administration ideal for Liraglutide, Ganciclovir, Posaconazole, "Making the Products of High Quality" is the eternal goal of our company. We make unremitting efforts to realize the goal of "We Will Always Keep in Pace with the Time".
Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai Detail:

Product name Methotrexate
Synonyms (+)-Amethopterin; (+)-4-Amino-10-methylfolic acid; N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamic acid
CAS No. 59-05-2
Appearance Yellow crystalline powder
Molecular Formula C20H22N8O5
Molecular Weight 454.44
Application Medicine grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Certificate of Analysis Test according to: EP9.0

Methotrexate CAS No.: 59-05-2

ITEMS

STANDARDS

RESULTS

Appearance Yellow or orange, crystalline, hygroscopic powder Complies
Identification IR;UV Complies
Solubility Practically insoluble in water, in ethanol(96%) and in methylene chloride. It dissolves in dilute mineral acids and in dilute solutions of alkali hydroxides and carbonates. Complies
Water ≤13% 11.8%
Related Substances Impurity B≤0.3%Impurity C≤0.5%Impurity E≤0.3%Impurity H≤0.2%Impurity I≤0.2%Unspecified Impurities≤0.05%

Sum of impurities other than B,C&E≤0.5%

0.04%0.45%0.03%NDND0.02%

0.04%

Enantiomeric Purity ≤3.0% 1.6%
Heavy Metals ≤20ppm  Complies
Sulphated Ash ≤0.1% 0.07%
Residual Solvents Ethyl ether≤500ppmAcetone≤1000ppmEthanol≤ 2000ppm 20ppm63ppm48ppm
Assay 97.0~102.0% 99.49%

 

Certificate of Analysis Test according to: USP32

Methotrexate CAS No.: 59-05-2

ITEMS

STANDARDS

RESULTS

CHARACTERISTICS Yellow crystalline powder Complies
IDENTIFICATION IR. UV Conform Complies
WATER ≤12%  10.8%
RESIDUE ON IGNITION ≤0.1% 0.07%
Chromatographic purity Single impurity:≤0.5% 0.27%
Total Impurities:≤2.0 % 0.73%
SPECIFIC ROTATION  Between  +19°to +24°  +21.25°
ASSAY 98.0~102.0% 99.27%

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai detail pictures

Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai detail pictures

Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai detail pictures


Related Product Guide:

While in the past few years, our organization absorbed and digested innovative technologies both equally at home and abroad. Meanwhile, our organization staffs a group of experts devoted for the advancement of Good Quality Anti-Tumor Drugs - High Purity USP BP EP 59-05-2 Methotrexate for Tumour Treatment – Yibai , The product will supply to all over the world, such as: Salt Lake City, Manila, Naples, Our stock have valued 8 million dollar , you can find the competitive parts within short delivery time. Our company is not only your partner in business, but also our company is your assistant in the coming corporation.
  • The product classification is very detailed that can be very accurate to meet our demand, a professional wholesaler.
    5 Stars By Andrew from India - 2017.06.19 13:51
    In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Flora from Ghana - 2018.11.02 11:11
    Write your message here and send it to us